Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Sep;48(9):300060520949657.
doi: 10.1177/0300060520949657.

Effect of vitamin E on stroke-associated pneumonia

Affiliations

Effect of vitamin E on stroke-associated pneumonia

Hongwei Shen et al. J Int Med Res. 2020 Sep.

Abstract

Objective: To study the role of vitamin E in stroke-associated pneumonia.

Methods: We selected 183 patients with stroke-related pneumonia who were divided into different nutrition groups according to the Mini Nutritional Assessment score. Patients were then administered different doses of vitamin E.

Results: CD55 and CD47 levels in patients taking vitamin E across different nutrition score groups were better than those in patients who did not use vitamin E. The levels of CD55 and CD47 and the duration of hospitalization were better in the high-dose vitamin E group than in the low-dose vitamin E group.

Conclusion: Vitamin E may have an auxiliary therapeutic effect in patients with stroke-associated pneumonia.

Keywords: CD47; CD55; Mini Nutritional Assessment; Vitamin E; neutrophil; polymorphic leukocyte; stroke-associated pneumonia.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Comparison of CD47 levels before and after administration in Group A. After administration: ▲compared with subgroup A1, P < 0.05; ◇compared with subgroup A2, P < 0.05.
Figure 2.
Figure 2.
Comparison of CD55 levels before and after administration in Group A. After administration: ▲compared with subgroup A1, P < 0.05; ◇compared with subgroup A2, P < 0.05.
Figure 3.
Figure 3.
Comparison of CD47 levels before and after administration in Group B. After administration: ▲ compared with subgroup B1, P < 0.05; ◇ compared with subgroup B2, P < 0.05.
Figure 4.
Figure 4.
Comparison of CD55 levels before and after administration in Group B. After administration: ▲ compared with subgroup B1, P < 0.05; ◇ compared with subgroup B2, P < 0.05.
Figure 5.
Figure 5.
Comparison of CD47 levels before and after administration in Group C. After administration: ▲ compared with subgroup C1, P < 0.05; ◇ compared with subgroup C2, P < 0.05.
Figure 6.
Figure 6.
Comparison of CD55 levels before and after administration in Group C. After administration: ▲ compared with subgroup C1, P < 0.05; ◇ compared with subgroup C2, P < 0.05.

References

    1. Hilker R, Poetter C, Findeisen N, et al. Nosocomial pneumonia after acute stroke: implications for neurological intensive care medicine. Stroke 2003; 34: 975–981. - PubMed
    1. Motorna NV, Rybalko SL, Starosyla DB, et al. The study of leukocyte phagocytic activity in the presence of herpetic infection and stroke. Wiad Lek 2018; 71: 155–159. - PubMed
    1. Rolston KV. The spectrum of pulmonary infections in cancer patients. Curr Opin Oncol 2001; 13: 218–223. - PubMed
    1. Liu Y, Bühring HJ, Zen K, et al. Signal regulatory protein (SIRPalpha), a cellular ligand for CD47, regulates neutrophil transmigration. J Biol Chem 2002; 277: 10028–10036. - PubMed
    1. Greenlee-Wacker MC, Rigby KM, Kobayashi SD, et al. Phagocytosis of Staphylococcus aureus by human neutrophils prevents macrophage efferocytosis and induces programmed necrosis. J Immunol 2014; 10: 4709–4717. - PMC - PubMed